Opus Genetics
Price & Volume
Stats
See more52W Range | $1.22-$5.81 |
Market Cap | $320.3M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $9.8M |
Revenue Growth (YoY) | -73.8% |
Gross Profit (12 Mos) | -$28.7M |
Diluted EPS | -$1.29 |
News
See moreYahoo Finance • 2 months ago
RBC Capital Bullish On Opus Genetics (IRD) Amid Limited Competition And De-Risked Setup
Yahoo Finance • 2 months ago
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
Yahoo Finance • 4 months ago
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
Yahoo Finance • 4 months ago
Here is Why Opus Genetics (IRD) is One of the Best Performing NASDAQ Stocks
About
CEO | Dr. George Magrath M.B.A., M.D., M.S. |
Address | 8 Davis Drive, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |